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Case report Low-concentration, continuous brachial plexus 
block in the management of Purple Glove 
Syndrome: a case report
Georgene Singh*1, Verghese T Cherian1 and Binu P Thomas2
Abstract
Introduction: Purple Glove Syndrome is a devastating complication of intravenous phenytoin administration. 
Adequate analgesia and preservation of limb movement for physiotherapy are the two essential components of 
management.
Case presentation: A 26-year-old Tamil woman from India developed Purple Glove Syndrome after intravenous 
administration of phenytoin. She was managed conservatively by limb elevation, physiotherapy and oral antibiotics. A 
20G intravenous cannula was inserted into the sheath of her brachial plexus and a continuous infusion of bupivacaine 
at a low concentration (0.1%) with fentanyl (2 μg/ml) at a rate of 1 to 2 ml/hr was given. She had adequate analgesia 
with preserved motor function which helped in physiotherapy and functional recovery of the hand in a month.
Conclusion: A continuous blockade of the brachial plexus with a low concentration of bupivacaine and fentanyl helps 
to alleviate the vasospasm and the pain while preserving the motor function for the patient to perform active 
movements of the finger and hand.
Introduction
Intravenous administration of phenytoin can result in
soft tissue injury at the site of injection leading to oedema
and purplish-black discolouration of the hand. This is
known as the Purple Glove Syndrome (PGS). The man-
agement of PGS is mainly conservative, which includes
limb elevation and physiotherapy. Use of low concentra-
tion of local anaesthetic for brachial plexus block has the
added advantage of preserving motor function to facili-
tate physiotherapy in addition to providing adequate
analgesia and relief of vasospasm.
Case presentation
A 26-year-old Tamil woman from India presented with
an alleged history of generalized seizures. The emer-
gency-room physician administered 600 mg of pheny-
toin-sodium dissolved in 500 ml of normal saline through
a 20G cannula sited into a vein on the dorsum of her right
hand. Four hours later, the patient complained of pain at
the site of injection, which progressively became severe.
The fingers, hand and forearm were swollen and had a
purplish-black discolouration (Figure 1a). The radial
artery was palpable, albeit feeble, under the oedema. The
capillary refill under the nail bed was sluggish. The ultra-
sonic Doppler study of the arm showed normal flow
through the radial and the ulnar arteries but the veins
appeared collapsed.
The working diagnosis was that the patient had an isch-
emic hand, with the likelihood of progression to gan-
grene. This was possibly due to the extravasation of
phenytoin leading to PGS. Although a differential diagno-
sis of compartment syndrome and need for fasciotomy to
relieve the pressure was considered, it was decided to
manage conservatively.
The intravenous cannula was removed and the arm was
wrapped in a dry cotton-gauze dressing and kept elevated
to reduce the oedema. Since the pain was intense and not
relieved with non-steroidal anti-inflammatory drugs, the
stellate ganglion was blocked using 7 ml of 0.5% bupiva-
caine. This sympathetic blockade improved the capillary
refill and the mottled discolouration, and significantly
reduced the pain. However, it lasted for only three hours.
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Therefore, it was planned to provide a continuous bra-
chial plexus block. A 20G intravenous cannula was
inserted into the interscalene grove 2.5 cm above the
clavicle and was directed distally to lie within the sheath
of the brachial plexus (Figure 2). A solution of 0.1% bupi-
vacaine with fentanyl (2 μg ml-1) was infused at a rate of
1-2 ml.hr-1 using a Terumo TE-311 infusion pump. The
patient had adequate pain relief without any motor weak-
ness. The swelling and the discolouration continued to
improve with limb elevation, physiotherapy and oral anti-
biotics. As there was sufficient improvement, the cannula
was left in-situ for seven days to provide analgesia and aid
in physiotherapy. The patient was discharged from the
hospital after ten days with advice to continue physio-
therapy. By the end of a month, the blackish discoloura-
tion had disappeared and the range of movement of the
hand was nearly back to normal (Figure 1b).
Discussion
PGS, named for its distinctive discolouration and swell-
ing of the hands is a known complication of intravenous
administration of phenytoin-sodium [1]. It is character-
ized by intense pain, purplish black discolouration and
oedema at the site of injection which progresses to rest of
the limb [2]. The reported incidence among patients is 1-
7% after intravenous injection of phenytoin [1,3,4]. It
should be differentiated from extravasation of intrave-
nous fluid, injection site infection and intra-arterial injec-
tion. The persistence of the pain, blackish discolouration
and the oedema even after discontinuation of the intrave-
nous fluid and removal of the cannula differentiates it
from extravasation. The lack of purulent discharge or
pyrexia differentiates it from injection site infection.
Intra-arterial injection of a highly alkaline solution would
l e a d  t o  a r t e r i a l  s p a s m ,  e m b o l i s a t i o n  o f  i n s o l u b l e  d r u g
crystals, endothelial damage and vascular thrombosis
resulting in the absence of Doppler signal from the artery
[5].
Phenytoin is a weak acid and is insoluble in water [3].
However, injectable preparation is highly alkaline as it
contains 45% propylene glycol as the solvent and 10%
alcohol in water with sodium hydroxide to adjust the pH
to 12 [1]. The pathophysiology of PGS is poorly under-
stood [3]. It has been suggested that the alkaline drug pre-
cipitates upon contact with blood and leaks out of the
vein, from around the cannula, and into the interstitial
t i s s u e  [ 1 ] .  T h i s  i s  l i k e l y  t o  h a p p e n  i n  a  s l o w  f l o w i n g
stream or if the cannula is kinked, leading to stasis.
Another possible mechanism could be that the highly
alkaline solution induces vasoconstriction of the vein
resulting in disruption of the endothelial-intercellular
junctions and seepage of the drug into the interstitial
space [1]. Extravasation of the highly albumin-bound (70-
90%) phenytoin increases the interstitial oncotic pressure
leading to oedema [1]. Propylene glycol with its high
osmolality causes necrosis of the tissue [1]. Although
20 G intravenous Cannula inserted into the interscalene 
groove for continuous infusion of bupivacaine (0.1%) with 
fentanyl (2 μg ml-1)
Figure 2 20 G intravenous Cannula inserted into the interscalene 
groove for continuous infusion of bupivacaine (0.1%) with fenta-
nyl (2 μg ml-1).
Patient's right hand (1a) At the onset of Purple Glove Syn-
drome and (1b) One month later demonstrating complete 
recovery of flexion
Figure 1 Patient's right hand (1a) At the onset of Purple Glove 
Syndrome and (1b) One month later demonstrating complete re-
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these explanations seem plausible, reports of PGS occur-
ring after the oral administration of phenytoin [6] also
suggest that the phenomenon may be due to phenytoin
itself and not directly due to the infusion [7].
Women and the elderly are said to have an increased
risk of PGS. Other factors associated with it include
peripheral vascular disease and diseases that weaken the
vascular and dermal integrity, use of intravenous cathe-
ters smaller than 20G and infusion of phenytoin at more
than 25 mg.ml-1 [1,8].
Therefore, administration of phenytoin should be into a
free-flowing infusion line, through a large bore intrave-
nous catheter sited into a large vein of the forearm, in a
concentration of 10 mg.ml-1, and at a rate not exceeding
50 mg.min-1 [9]. Any evidence of venous irritation such as
pain, oedema and erythema warrants immediate discon-
tinuation of the infusion and removal of the intravenous
catheter [1].
The diagnosis of PGS is based on the characteristic
clinical findings and a high index of suspicion when it
occurs after the administration of phenytoin. The man-
agement is mainly conservative (limb elevation, physio-
therapy, control of pain, reassurance to the patient) and
should be directed at minimizing the degree of soft tissue
damage [1]. The affected arm should not be used for
venepuncture or blood pressure measurement.
Arterioles, smaller arteries and peripheral veins are
normally under vasoconstrictor influence by the alpha
receptors. In addition to the vasoconstriction caused by
the highly alkaline solution, pain and anxiety also cause a
marked increase in arteriolar vasoconstriction mediated
by the sympathetic nervous system. This results in
increased resistance, reducing cutaneous perfusion. In
addition, there is an associated increase in vascular tone
which decreases the compliance of the venous system,
reducing its blood content and increasing the venous
pressure. Sympathetic blockade, by blocking the alpha
receptors, improves blood flow in vasospastic disorders
[10]. Stellate ganglion blockade has the advantage of
blocking the sympathetic innervation of the upper limb,
thus improving the perfusion and relieving the ischaemic
pain associated with vasospasm [11].
Because of tissue injury and ischaemia, PGS is very
painful. A low concentration local anaesthetic would
relieve the pain by preferentially blocking the Aδ and B
fibres [12]. Impulses in small fibres are blocked faster
than those in larger ones because of the amount of time
of drug diffusion and the length of the nerve to block
propagation of nerve impulses. In separate experiments,
it has been shown that nerve signals associated with both
beta fibres and A delta fibres are reduced at low concen-
tration of local anaesthetics [13]. Electrophysiologic stud-
ies have shown that bupivacaine diffuses relatively slowly
into fast conducting motor fibres at low concentrations
[14].
Selective sensory blockade, by preserving motor inner-
vation, allows the patient to move his or her fingers. This
helps in performing physiotherapy and improving venous
blood flow, both of which are crucial to recovery.
Infraclavicular approach to brachial plexus may also be
employed and a subcutaneously tunneled catheter may be
placed, especially if it is anticipated that the patient will
have difficulty in retaining the catheter without displace-
ment. Accurate placement may be confirmed using a
nerve stimulator or ultrasound guidance. In our case, as
even the tactile stimuli were excruciating, peripheral
nerve stimulator was not used.
Ropivacaine is another agent that may be considered
for low concentration brachial plexus blockade. The
degree of motor blockade produced by ropivacaine is less
than that of bupivacaine. So it is possible to produce a
more selective sensory blockade with ropivacaine. Fur-
thermore, if required, higher concentration of ropiva-
caine may be used with lesser risk of cardiotoxicity than
with bupivacaine [15].
Addition of fentanyl potentiates local anaesthetic
action via central opioid receptor mediated analgesia by
peripheral uptake of fentanyl to systemic circulation. Fen-
tanyl also acts directly on the peripheral neuronal cells as
the dorsal roots contain opioid binding sites. In addition,
because of the presence of bidirectional axonal transport
of opioid binding protein, fentanyl penetrates the nerve
membrane and acts at the dorsal horn [16]. Adjuvants
such as ketamine, alpha 2 adrenergic agonists have also
been used to potentiate the effects of local anaesthetics in
brachial plexus blocks [17].
Although brachial plexus blockade has been used for
this condition [18], to the best of our knowledge, the use
of low-dose bupivacaine (concentration and volume) that
has the added advantage of preserving the motor func-
tion of patients to perform active physiotherapy has not
been described before.
Conclusion
Intravenous administration of phenytoin should be
undertaken with care, ensuring a rate less than 50 mg per
minute [9], through a free-flowing infusion. The manage-
ment of PGS is primarily conservative. A continuous
blockade of the brachial plexus with a low concentration
of bupivacaine and fentanyl helps to alleviate the vasos-
pasm and the pain while preserving the motor function
for the patient to perform active movements of the finger
and hand.
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